News

AddToAny

Google+ Facebook Twitter Twitter

Diagnosing prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour higher-risk cancer in their prostate glands, according to new research.

The study is the first to report that genetic alterations associated with intermediate- and high-risk prostate cancer also may be present in some low-risk cases.

The study found the needle biopsy procedure may miss higher-risk cancer that increases the risk of disease progression. The researchers said that men diagnosed with low-risk cancer may benefit from additional testing for these chromosomal alterations.

George Vasmatzis, lead researcher, said: “We have discovered molecular markers that can help guide men in their decisions about the course of their prostate cancer care.

“We found that the presence of genetic alterations in low-risk cancer can help men decide whether treatment or active surveillance is right for them.”

Picture credit | iStock

Related Articles

p8-11-news-lego-blocks-istock-459012875.jpg

Imaging with LEGO

Researchers have come up with an inexpensive, automated way to image biological samples – using the children’s toy, LEGO.

megan-clarke-and-team_edit.jpg

My Lab: dynamic histopathology service

Trainee Specialist Biomedical Scientist Megan Clarkson gives a guided tour of her laboratory at Salford Royal NHS Foundation Trust.

sarah_may_bw.jpg

Equality of opportunity

There is no place for outdated prejudice if there is a serious desire for change. 

My ibms Samples iStock

The journey of a sample

For Healthcare Science Week, which ran from 8 to 17 March, the IBMS made three videos that detail what happens to samples given at GP surgeries.

Top